Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Celtaxsys obtains anti-inflammatory drug from Estrellita Pharmaceuticals

Jan. 12, 2012

Novel anti-inflammatory agents discovered in U.K.

Jan. 11, 2012

Novel inhibitors of cytochrome P450 enzymes synthesized by Angion Biomedica

Jan. 5, 2012

Lilly withdraws Xigris worldwide following PROWESS-SHOCK study

Oct. 26, 2011

Karolinska Institutet presents novel series of selenium-containing antioxidants

May 6, 2011

Phase I trial to assess MLN-9708 in relapsed/refractory light chain amyloidosis under way

March 28, 2011

Roskamp Institute obtains IRB approval for study of RCP-006 in humans

March 4, 2011

AM-095 displays antifibrotic activity in vivo

Jan. 13, 2011

AZD-9773 enters phase IIb trial in patients with severe sepsis and/or septic shock

Oct. 26, 2010

Almirall identifies new naphthyridine N-oxide as anti-inflammatory agent

Sep. 21, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.